BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+5.04%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.97B
AUM Growth
-$106M
(-1.5%)
Cap. Flow
-$278M
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
34.81%
Holding
187
New
15
Increased
42
Reduced
87
Closed
11
Top Buys
| 1 |
Revolution Medicines
RVMD
|
$25.6M |
| 2 |
Celldex Therapeutics
CLDX
|
$24.6M |
| 3 |
Exact Sciences
EXAS
|
$12.1M |
| 4 |
Tandem Diabetes Care
TNDM
|
$12M |
| 5 |
Charles River Laboratories
CRL
|
$6.28M |
Top Sells
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$91.2M |
| 2 |
Sarepta Therapeutics
SRPT
|
$42.4M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$26.3M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$20.3M |
| 5 |
Axsome Therapeutics
AXSM
|
$14.3M |
Sector Composition
| 1 | Healthcare | 99.34% |
| 2 | Industrials | 0.59% |
| 3 | Energy | 0.02% |
| 4 | Communication Services | 0.01% |
| 5 | Technology | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Procept Biorobotics
PRCT
$2.13B
| $24.4M | 0.35% |
589,262
-6,118
| -1% | -$254K |
|
77
Adaptive Biotechnologies
ADPT
$1.98B
| $23.4M | 0.34% |
3,279,620
-259,435
| -7% | -$1.85M |
|
|
78
Axsome Therapeutics
AXSM
$6.21B
| $22.2M | 0.32% |
496,524
-320,617
| -39% | -$14.3M |
|
79
CVS Health
CVS
$93.5B
| $21.5M | 0.31% |
225,114
-4,039
| -2% | -$385K |
|
80
Cooper Companies
COO
$13.5B
| $21.5M | 0.31% |
325,252
-664
| -0.2% | -$43.8K |
|
81
Aurinia Pharmaceuticals
AUPH
$1.65B
| $21.4M | 0.31% |
2,846,457
+175,044
| +7% | +$1.32M |
|
82
BioNTech
BNTX
$24.9B
| $20.7M | 0.3% |
153,580
+2,380
| +2% | +$321K |
|
83
Generation Bio
GBIO
$38.9M
| $19.3M | 0.28% |
362,728
| – | – |
|
|
HZNP
84
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $18.7M | 0.27% |
301,850
-35,584
| -11% | -$2.2M |
|
85
ResMed
RMD
$40.1B
| $18.5M | 0.27% |
84,612
-253
| -0.3% | -$55.2K |
|
86
Privia Health
PRVA
$2.84B
| $17.5M | 0.25% |
515,030
-4,846
| -0.9% | -$165K |
|
87
Baxter International
BAX
$12.1B
| $17.2M | 0.25% |
319,548
-138,271
| -30% | -$7.45M |
|
88
Phreesia
PHR
$1.86B
| $17M | 0.24% |
666,419
-13,734
| -2% | -$350K |
|
89
Illumina
ILMN
$15.5B
| $16.4M | 0.24% |
88,333
-966
| -1% | -$179K |
|
90
Wave Life Sciences
WVE
$1.3B
| $16.2M | 0.23% |
4,494,458
| – | – |
|
91
Hologic
HOLX
$14.8B
| $16.2M | 0.23% |
251,412
-19,413
| -7% | -$1.25M |
|
92
HUTCHMED
HCM
$2.55B
| $15.9M | 0.23% |
1,758,075
+1,768
| +0.1% | +$16K |
|
93
Align Technology
ALGN
$9.76B
| $15.5M | 0.22% |
74,939
-60,301
| -45% | -$12.5M |
|
94
Scholar Rock
SRRK
$3.12B
| $14.9M | 0.21% |
2,152,025
| – | – |
|
|
NVRO
95
DELISTED
NEVRO CORP.
NVRO
| $12.2M | 0.17% |
260,835
-4,504
| -2% | -$210K |
|
96
Regeneron Pharmaceuticals
REGN
$60.1B
| $12M | 0.17% |
17,389
-338
| -2% | -$233K |
|
97
ESSA Pharma
EPIX
$11M
| $10.7M | 0.15% |
5,898,583
+888,869
| +18% | +$1.62M |
|
98
Amgen
AMGN
$151B
| $10.2M | 0.15% |
45,196
-5,763
| -11% | -$1.3M |
|
99
Teladoc Health
TDOC
$1.35B
| $9.89M | 0.14% |
390,286
-25,826
| -6% | -$655K |
|
100
Avantor
AVTR
$8.99B
| $9.86M | 0.14% |
503,007
| – | – |
|